• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP NEWS SCAN: Reduced-dose polio vaccine, pertussis vaccine 'cocooning' strategy

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/cidrap/content/other/news/jan3013scan.html

NEWS SCAN: Reduced-dose polio vaccine, pertussis vaccine 'cocooning' strategy

Jan 30, 2013

Using reduced dose of inactivated polio vaccine looks promising in infants
Vaccinating infants with a reduced dose of inactivated polio vaccine (IPV) induces a priming response and seroconversion, suggesting that this approach could play a role in preventing a return of polio after its global elimination, according to a report today in the New England Journal of Medicine. The article notes that the World Health Organization has a goal of phasing out oral polio vaccines (OPVs) after eradication of wild polioviruses, since OPVs use live attenuated viruses that in rare cases can turn virulent and spread. Posteradication plans include using IPVs, which are injected and cost much more than OPVs. One strategy for lowering the cost of IPV in developing countries is to reduce the size and number of doses. The authors conducted a trial in which 320 Cuban infants were randomly assigned to receive a fractional intradermal dose or a full intramuscular dose of IPV at the ages of 4 and 8 months. After the first dose, seroconversion rates for all three poliovirus types were significantly lower in the fractional-dose group than in the full-dose group. A priming response was defined as the absence of seroconversion after the first dose and a fourfold increase in antibody titer between the time of the second dose and 1 week later. After the second dose, cumulative two-dose seroconversion for virus types 1, 2, and 3 occurred in 93.6%, 98.1%, and 93.0% of the fractional dose recipients, versus 100%, 100%, and 99.4% in the full-dose group. The authors say the findings show that using a single fractional dose of IPV is a "feasible, lower-cost alternative to schedules in which multiple full doses are used."
Jan 31 N Engl J Med report

Study finds 'cocooning' strategy inefficient where pertussis levels are low
"Cocooning" vaccination strategies?in which parents are vaccinated to protect their infants?are inefficient for reducing infant pertussis hospitalizations in areas where the overall incidence of the disease is low, according to new findings from Italian researchers. They estimated the costs and benefits of the strategy in the Piemonte, Italy, region, where incidence dropped to a low of .85 cases per 100,000 population in 2010. Researchers assessed the number needed to vaccinate (NNV) to prevent hospital admission in infants during the most recent epidemic cycle from 2005 to 2010. They found that the NNV was 5,000 to prevent one infant hospitalization. They wrote that their data confirm recent findings from two Canadian provinces that had low pertussis rates in 2010. Cocooning vaccination programs should take into account the epidemiologic pattern of the disease in the region where officials are considering the strategy, they wrote. For example, in the United States, which is experiencing a spike in cases, the national incidence is much higher, at 11.6 per 100,000 persons, according to late November numbers from the Centers for Disease Control and Prevention (CDC) that indicate pertussis cases at their highest since 1955. Infants are at greatest risk for getting pertussis, but they can't get their first dose until they are 2 months old. Health officials recommend protecting babies by vaccinating pregnant women, preferably in their third trimester, and vaccinating infants' household contacts.
Jan 29 Vaccine abstract
CDC pertussis vaccine outbreak page
 
Back
Top Bottom